https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Heart-MS.jpg

Cardiac Surgery Market Analysis, Size, Trends | United States | 2020-2026 | COVID19 | MedSuite

  • Year: 2020
  • Scope: 2016-2026
  • Region: United States
  • Pages: 618
  • Published Date: 10/08/2020
  • Type: MedSuite

By 2020, the U.S. cardiac surgery market size was valued at $7.2 billion, with over 91,000 transcatheter heart valve replacement (TAVR) procedures performed every year. The market size is expected to increase at a growth rate of 7.7% to reach $12.1 billion in 2026.

Throughout this medical market research, we analyzed 43 cardiac surgery companies across the United States and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all of the US Cardiac Surgery Device market analysis and data, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Procedure Volumes for the Cardiac Surgery Devices
  • Market Forecasts Until 2026, and Historical Data to 2016
  • Competitive Analysis with Market Shares for Each Segment
  • Market Drivers & Limiters for Each Cardiac Surgery Device Market
  • Recent Mergers & Acquisitions
  • COVID19 Impact on the Cardiac Surgery Device Market in the US
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Cardiac Surgery Market Insights

A major limiter to the cardiac surgery market is the limited clinical data available for some of the newer markets. Growth in the cerebral embolic protection (CEPD) market may be limited until a large randomized clinical trial is conducted to determine the device’s exact role in reducing cerebral ischemic volumes. The CEPD market has experienced strong growth in recent years but may be unable to reach its full market potential without this additional clinical data.

US Cardiac Surgery Market Size by Segment, 2016-2026

A major driver in the cardiac surgery market is the patient population, which is large for many of the indications for cardiac surgery devices. Approximately 1.2 million people in the U.S. have calcified or otherwise damaged aortic valves. This condition is typically present in patients who have several other co-morbidities, making them poor candidates for open, invasive surgery. Similarly, children with congenital defects would benefit from a percutaneous approach because they would not have to undergo repeated invasive procedures as they age.

COVID19 Impact on Cardiac Surgery Market in the US

The invasive cardiac surgery market is likely to be impacted the most severely by COVID-19. It is likely that the on-pump coronary artery bypass and off-pump coronary artery bypass market segments will decline as less invasive methods of treatment are preferred. This is expected to have a knock-on effect on other devices used in invasive surgery, such as anastomosis assist devices and endoscopic vessel harvesting devices.

The COVID19 impact on the transcatheter heart valve replacement (TAVR) market is likely to be similar to the balloon valvuloplasty, cerebral embolic protection, and preshaped guidewire markets. Conversely, the transcatheter mitral valve repair (TMVR) market will be severely impacted, as these procedures are resource-intensive and time-consuming. Overall, the US cardiac surgery market is expected to return to pre-COVID19 levels in early- / mid-2021.

Cardiac Surgery Market Share Insight

US Cardiac Surgery Market Share Leaders

By 2020, Edwards Lifesciences was the competitive leader of the cardiac surgery and heart valve device market in the US. The company generated the majority of its total cardiac surgery and heart valve device revenue in the high-value transcatheter aortic valve replacement market. Edward’s Lifesciences pioneered the transcatheter aortic valve replacement segment, which is expected to experience significant growth propelled by the expanding indications for Edward’s devices to include low-risk patients.

Abbott was the second-leading competitor in the US cardiac surgery market by 2020. The company is the only competitor in the transcatheter mitral valve repair (TMVR) market, with its MitraClip™. The market is set to experience significant growth following approval of the device for secondary mitral regurgitation. Abbott is also the leading competitor in multiple structural heart defect occlusion devices.

The third-leading competitor in the cardiac surgery market in the US was Medtronic. The company’s strong position comes from its presence in the transcatheter heart valve replacement segment, with its CoreValve Evolut R® Transcatheter Aortic Valve Replacement product.

Detailed Market Segmentation

Each of the markets below is available for purchase as a standalone report, a MedCore.

  • Procedure Volumes for Cardiac Surgery Market– MedPro – Using a number of databases, internal and external, we’re able to provide you with the volume of cardiac surgery procedures being performed in the US, including Surgical Heart Valve Replacement, Annuloplasty Repair, Transcatheter Mitral Valve Repair, Transcatheter Aortic Valve Replacement, Coronary Artery Bypass Grafting, Ventricular Assist Device, Heart Transplant, Intra-Aortic Balloon Counterpulsation, Atrial & Ventricular Septal Defect Closure, Left Atrial Appendage Closure procedures, and more.
  • Tissue Heart Valve Market – MedCore – The market is further broken down into segments by:
    • Device Type: Stented, Stentless, Covered Stents, and Sutureless/Rapid Deployment;
    • Tissue Type: Xenograft and Allograft.
  • Mechanical Heart Valve Market – MedCore – The market is also further segmented by Device Type into with and without conduit markets.
  • Annuloplasty Repair Device Market – MedCore – The chapter contains the market analysis which is categorized by Ring and Band devices.
  • Transcatheter Mitral Valve Repair Device Market – MedCore – In-depth analysis of the Transcatheter Mitral Valve Repair Device market.
  • Transcatheter Heart Valve Replacement Market – MedCore – The market and its analysis are categorized into Transcatheter Aortic Value Replacement and Transcatheter Pulmonary Value Replacement markets.
  • Cerebral Embolic Protection Device Market – MedCore – In-depth analysis of the Cerebral Embolic Protection Device market.
  • Balloon Valvuloplasty Market – MedCore – The chapter is further broken down to Aortic, Mitral, Pulmonary, and Hybrid devices.
  • On-Pump Coronary Artery Bypass Device Market – MedCore – The market is further broken down into ONCAB Disposables and Perfusion System market segments.
  • Off-Pump Coronary Artery Bypass Device Market – MedCore – The analysis is further segmented by Stabilizer Device, Positioner, and OPCAB Accessories markets.
  • Autotransfusion Device Market – MedCore – This market consists of the segments for the Autotransfusion Machine and Disposables.
  • Endoscopic Vessel Harvesting Device Market – MedCore – The in-depth analysis of the Endoscopic Vessel Harvesting Device Market.
  • Anastomosis Assist Device (AAD) Market – MedCore – The chapter takes a closer look at the different market segments, including Distal and Proximal anastomosis assist devices.
  • Transmyocardial Revascularization Market – MedCore –The market analysis includes the segments, such as Single-Use Fibre-Optic Handpiece and TMR Laser Console markets.
  • Ventricular Assist Device (VAD) Market – MedCore – The market analysis is further broken down by Device Type into Percutaneous, Implantable, and External VAD markets.
  • Intra-Aortic Balloon Pump Market – MedCore – The analysis includes the Intra-Aortic Balloon Pump Catheter and Console markets.
  • Artificial Heart Replacement Device Market – MedCore – In-depth analysis of the Artificial Heart Replacement Device market.
  • Remote Hemodynamic Monitoring System Market – MedCore – In-depth analysis of the Remote Hemodynamic Monitoring System market.
  • Patent Foramen Ovale Closure Device Market – MedCore – In-depth analysis of the Patent Foramen Ovale Closure Device market.
  • Patent Ductus Arteriosus Closure Device Market – MedCore – In-depth analysis of the Patent Ductus Arteriosus Closure Device market.
  • Atrial Septal & Ventricular Septal Defect Closure Device Market – MedCore – The chapter contains the market analysis categorized by Atrial Septal Defect Closure and Ventricular Septal Defect Closure devices.
  • Left Atrial Appendage Closure Device Market – MedCore – The market is further segmented by Device Type, such as Epicardial Device and Endocardial Device markets.
  • Preshaped Guidewire Market – MedCore – In-depth analysis of the Patent Foramen Ovale Closure Device market.
  • Extracorporeal Membrane Oxygenation Market – MedCore – The detailed analysis of the Extracorporeal Membrane Oxygenation Market.

DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

TABLE OF CONTENTS FOR THE US CARDIAC SURGERY MARKET REPORT SUITE

TABLE OF CONTENTS I
LIST OF FIGURES XVI
LIST OF CHARTS XXVII
EXECUTIVE SUMMARY 1
U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 8
MARKET DEVELOPMENTS 13
PROCEDURE NUMBERS 14
PROCEDURE CODES INVESTIGATED 18
MARKETS INCLUDED 19
KEY REPORT UPDATES 23
VERSION HISTORY 24
RESEARCH METHODOLOGY 25
Step 1: Project Initiation & Team Selection 25
Step 2: Prepare Data Systems and Perform Secondary Research 28
Step 3: Preparation for Interviews & Questionnaire Design 30
Step 4: Performing Primary Research 31
Step 5: Research Analysis: Establishing Baseline Estimates 33
Step 6: Market Forecast and Analysis 34
Step 7: Identify Strategic Opportunities 36
Step 8: Final Review and Market Release 37
Step 9: Customer Feedback and Market Monitoring 38

DISEASE OVERVIEW

2.1 BASIC ANATOMY 39
2.2 DISEASE TREATMENTS & DIAGNOSTICS
2.2.1 Coronary Artery Disease 41
2.2.2 Myocardial Infarction 41
2.2.3 Angina Pectoris 42
2.2.4 Heart Valve Disease 43
2.2.5 Congestive Heart Failure 43
2.2.6 Aortic Stenosis 44
2.2.7 Degenerative/Functional Mitral Regurgitation 46
2.3 PATIENT DEMOGRAPHICS 47
2.3.1 General Statistics 47

PRODUCT ASSESSMENT

3.1 INTRODUCTION 48
3.2 PRODUCT PORTFOLIOS 48
3.2.1 Tissue Heart Valve Device 48
3.2.2 Mechanical Heart Valve Device 51
3.2.3 Annuloplasty Repair Device 53
3.2.4 Transcatheter Mitral Valve Repair Device 55
3.2.5 Transcatheter Heart Valve Replacement Device 56
3.2.6 Cerebral Embolic Protection Device 58
3.2.7 Balloon Valvuloplasty Device 59
3.2.8 On-Pump Coronary Artery Bypass Device 60
3.2.9 Off-Pump Coronary Artery Bypass Device 62
3.2.10 Autotransfusion Device 63
3.2.11 Endoscopic Vessel Harvesting Device 65
3.2.12 Anastomosis Assist Device 66
3.2.13 Transmyocardial Revascularization Device 67
3.2.14 Ventricular Assist Device 68
3.2.15 Intra-Aortic Balloon Pump Device 69
3.2.16 Artificial Heart Replacement Device 70
3.2.17 Remote Hemodynamic Monitoring System Device 71
3.2.18 Patent Foramen Ovale Device 72
3.2.19 Patent Ductus Arteriosus Closure Device 73
3.2.20 Atrial & Ventricular Septal Defect Device 75
3.2.21 Left Atrial Appendage Closure Device 76
3.2.22 Preshaped Guidewires 77
3.3 REGULATORY ISSUES AND RECALLS 78
3.4 CLINICAL TRIALS 101
3.4.1 Abbott 101
3.4.2 CryoLife 105
3.4.3 Edwards LifeSciences 106
3.4.4 Medtronic 111

IMPACT OF COVID-19 ON U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET

4.1 INTRODUCTION 112
4.2 MULTI-SCENARIO ANALYSIS 115
4.2.1.1 Best Case Scenario 115
4.2.1.2 Base Case Scenario 118
4.2.1.3 Worst Case Scenario 121

U.S. CARDIAC SURGERY AND HEART VALVE DEVICE MARKET BY SEGMENT MARKET OVERVIEW

5.1 INTRODUCTION 125
5.2 MARKET OVERVIEW 127
5.3 TREND ANALYSIS BY SEGMENT 134
5.4 DRIVERS AND LIMITERS 139
5.4.1 Market Drivers 139
5.4.2 Market Limiters 140
5.5 COMPETITIVE MARKET SHARE ANALYSIS 142
5.6 MERGERS AND ACQUISITIONS 150
5.7 COMPANY PROFILES 153
5.7.1 Abbott 153
5.7.2 Abiomed 155
5.7.3 AtriCure 156
5.7.4 Boston Scientific 157
5.7.5 CryoLife 158
5.7.6 Edwards LifeSciences 159
5.7.7 LivaNova 160
5.7.8 Getinge 161
5.7.9 Medtronic 162
5.7.10 Teleflex 162
5.7.11 Terumo 164
5.8 SWOT ANALYSIS 165
5.8.1 Abbott 166
5.8.2 Abiomed 167
5.8.3 AtriCure 168
5.8.4 Boston Scientific 169
5.8.5 CryoLife 170
5.8.7 Edwards LifeSciences 171
5.8.8 LivaNova 172
5.8.10 Getinge 173
5.8.11 Medtronic 174
5.8.12 Teleflex 175
5.8.13 Terumo 176

PROCEDURE NUMBERS

6.1 INTRODUCTION 177
6.2 CARDIAC SURGERY AND HEART VALVE PROCEDURES 178
6.3 SURGICAL HEART VALVE REPLACEMENT PROCEDURES 183
6.3.1 Tissue Heart Valve Procedures by Valve Type 185
6.3.2 Tissue Heart Valve Procedures by Device Type 187
6.3.3 Tissue Heart Valve Procedures by Tissue Type 189
6.3.4 Mechanical Heart Valve Replacement Procedures by Valve Type 191
6.3.5 Mechanical Heart Valve Replacement Procedures by Tissue Type 193
6.4 ANNULOPLASTY REPAIR PROCEDURES 195
6.4.1 Annuloplasty Repair Procedures by Valve Type 195
6.4.2 Annuloplasty Repair Procedures by Device Type 197
6.5 TRANSCATHETER MITRAL VALVE REPAIR PROCEDURES 199
6.5.1 Transcatheter Mitral Valve Procedures by Approach 200
6.5.2 Transcatheter Mitral Valve Repair Procedures by Disease 202
6.6 TRANSCATHETER HEART VALVE REPLACEMENT PROCEDURES 204
6.6.1 Transcatheter Heart Valve Replacement Procedures by Valve Type 204
6.6.1.1 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Approach 206
6.6.1.2 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Patient Risk Class 208
6.6.1.3 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Embolic Protection 210
6.6.1.4 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Therapy 212
6.6.1.5 Transcatheter Aortic Valve Replacement (TAVR) Procedures by Location 214
6.7 BALLOON VALVULOPLASTY PROCEDURES 216
6.8 CABG PROCEDURES 218
6.8.1 CABG Procedures by Support Type 220
6.8.2 CABG Vessel Harvesting Procedures by Type 222
6.8.3 CABG Procedures by Suture Type 224
6.8.4 CABG Procedures by Approach 226
6.9 TRANSMYOCARDIAL REVASCULARIZATION PROCEDURES 229
6.10 VENTRICULAR ASSIST DEVICE PROCEDURES 231
6.10.1 Ventricular Assist Procedures by Device Type 231
6.10.1.1 Percutaneous Ventricular Assist Procedures by Heart Side 233
6.10.1.2 Percutaneous Ventricular Assist Procedures by Indication 235
6.10.1.3 Implantable Ventricular Assist Procedures by Indication 237
6.10.1.4 Implantable Ventricular Assist Procedures by Area 239
6.10.1.5 External Ventricular Assist Procedures by Device Type 241
6.11 INTRA-AORTIC BALLOON COUNTERPULSATION PROCEDURES 243
6.11.1 Intra-Aortic Balloon Counterpulsation Procedures by Setting 243
6.11.2 Intra-Aortic Balloon Counterpulsation Procedures by Device Type 245
6.12 HEART TRANSPLANT PROCEDURES 247
6.13 REMOTE HEMODYNAMIC MONITORING DEVICE IMPLANTATION PROCEDURES 249
6.14 PATENT FORAMEN OVALE CLOSURE PROCEDURES 251
6.15 PATENT DUCTUS ARTERIOSUS CLOSURE PROCEDURES 253
6.16 SEPTAL DEFECT CLOSURE PROCEDURES 255
6.16.1 Septal Defect Closure Procedures by Anatomy 255
6.17 LEFT ATRIAL APPENDAGE CLOSURE PROCEDURES 257
6.17.1 Left Atrial Appendage Closure Procedures by Type 258
6.17.1.1 Epicardial Device Procedures by Device Type 260
6.17.1.1.1 Epicardial Clip Device Procedures by Approach 262

TISSUE HEART VALVE MARKET

7.1 INTRODUCTION 264
7.2 MARKET OVERVIEW 266
7.2.1 Tissue Heart Valve Market by Device Type 267
7.2.2 Tissue Heart Valve Market by Tissue Type 271
7.3 MARKET ANALYSIS AND FORECAST 275
7.3.1 Total Tissue Heart Valve Market 275
7.3.2 Tissue Heart Valve Market by Device Type 277
7.3.2.1 Stented Tissue Heart Valve Market 277
7.3.2.2 Sutureless/Rapid Deployment Tissue Heart Valve Market 279
7.3.2.3 Stentless Tissue Heart Valve Market 281
7.3.3 Tissue Heart Valve Market by Tissue Type 283
7.3.3.1 Xenograft Tissue Heart Valve Market 283
7.3.3.2 Allograft Tissue Heart Valve Market 285
7.4 DRIVERS AND LIMITERS 287
7.4.1 Market Drivers 287
7.4.2 Market Limiters 287
7.5 COMPETITIVE MARKET SHARE ANALYSIS 289

MECHANICAL HEART VALVE MARKET

8.1 INTRODUCTION 292
8.2 MARKET OVERVIEW 293
8.3 MARKET ANALYSIS AND FORECAST 297
8.3.1 Total Mechanical Heart Valve Market 297
8.3.2 Mechanical Heart Valve without Conduit Market 299
8.3.3 Mechanical Heart Valve with Conduit Market 301
8.4 DRIVERS AND LIMITERS 303
8.4.1 Market Drivers 303
8.4.2 Market Limiters 304
8.5 COMPETITIVE MARKET SHARE ANALYSIS 305

ANNULOPLASTY REPAIR DEVICE MARKET

9.1 INTRODUCTION 308
9.2 MARKET OVERVIEW 310
9.3 MARKET ANALYSIS AND FORECAST 314
9.3.1 Total Annuloplasty Repair Device Market 314
9.3.2 Ring Device Market 316
9.3.3 Band Device Market 318
9.4 DRIVERS AND LIMITERS 320
9.4.1 Market Drivers 320
9.4.2 Market Limiters 321
9.5 COMPETITIVE MARKET SHARE ANALYSIS 322

TRANSCATHETER MITRAL VALVE REPAIR DEVICE MARKET

10.1 INTRODUCTION 325
10.2 MARKET ANALYSIS AND FORECAST 326
10.3 DRIVERS AND LIMITERS 328
10.3.1 Market Drivers 328
10.3.2 Market Limiters 329
10.4 COMPETITIVE MARKET SHARE ANALYSIS 331
10.4.1 Potential Competitors 331

TRANSCATHETER HEART VALVE REPLACEMENT DEVICE MARKET

11.1 INTRODUCTION 335
11.2 MARKET OVERVIEW 337
11.3 MARKET ANALYSIS AND FORECAST 341
11.3.1 Total Transcatheter Heart Valve Replacement Device Market 341
11.3.2 Transcatheter Aortic Valve Replacement Device Market 343
11.3.3 Transcatheter Pulmonary Valve Replacement Device Market 346
11.4 DRIVERS AND LIMITERS 348
11.4.1 Market Drivers 348
11.4.2 Market Limiters 349
11.5 COMPETITIVE MARKET SHARE ANALYSIS 351
11.5.1 Potential Competitors 352

CEREBRAL EMBOLIC PROTECTION DEVICE MARKET

12.1 INTRODUCTION 355
12.2 MARKET ANALYSIS AND FORECAST 356
12.3 DRIVERS AND LIMITERS 358
12.3.1 Market Drivers 358
12.3.2 Market Limiters 358
12.4 COMPETITIVE MARKET SHARE ANALYSIS 360

For a Full Table of Contents, please contact iData.
The Cardiac Surgery Market Report Suite| United States | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • Abbott
  • Abiomed
  • Angel Valve Vienna
  • AtriCure
  • B. Braun
  • Becton Dickinson
  • Berlin Heart
  • Biostable
  • Blue Sail
  • Boston Scientific
  • Cardia
  • Cardiac Dimensions
  • Cardio Mech
  • CARMAT
  • Chase Medical
  • Colibri Heart Valve
  • Cook Medical
  • CoreMedic
  • CryoLife
  • Edwards Lifesciences
  • Genesee Biomedical
  • Getinge
  • Gore
  • JenaValve
  • Karl Storz
  • LifeNet Health
  • LivaNova
  • Medtronic
  • Meril Life Sciences
  • Mitralign
  • NeoChord
  • Occlutech
  • Peters Surgical
  • PFM Medical
  • Saphena Medical
  • SentreHeart
  • SynCardia
  • TandemLife
  • Teleflex
  • Terumo
  • Thubrikar Aortic Valve
  • Toray
  • Venus Medtech

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology